(0.12%) 5 252.50 points
(0.08%) 39 672 points
(0.20%) 18 292 points
(0.36%) $78.54
(0.89%) $2.27
(-1.13%) $2 348.10
(-0.58%) $28.34
(-0.01%) $1 007.10
(-0.09%) $0.927
(0.15%) $10.85
(-0.03%) $0.798
(-1.38%) $91.39
4 days till quarter result
(tns 2024-05-17)
Expected move: +/- 7.12%
Live Chart Being Loaded With Signals
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases...
Stats | |
---|---|
Today's Volume | 3.00 |
Average Volume | 1 737.00 |
Market Cap | 2.21M |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $0 ) 2024-05-17 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.170 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-08-01 | Biunno Jeffrey Francis | Buy | 26 203 | Common Stock |
2022-08-01 | Sarret Joseph J. | Buy | 131 017 | Common Stock |
2022-07-11 | Tozzo Stephanie | Buy | 200 000 | Stock Option (Right to buy) |
2022-07-11 | Tozzo Stephanie | Buy | 0 | |
2021-12-29 | Biunno Jeffrey Francis | Buy | 75 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 7 451 858 | Sell: 253 700 |
CohBar Inc Correlation
10 Most Positive Correlations | |
---|---|
YJ | 0.911 |
EFOI | 0.867 |
PRVB | 0.865 |
SMED | 0.863 |
CXSE | 0.859 |
PXLW | 0.857 |
HLBZ | 0.856 |
PCTTU | 0.849 |
MCHI | 0.848 |
WB | 0.839 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CohBar Inc Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-4.13 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-4.13 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-9.51 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-10.00 |
Financial Reports:
No articles found.
CohBar Inc
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators